Patricia Aldea

2.8k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Patricia Aldea is a scholar working on Physiology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patricia Aldea has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Psychiatry and Mental health and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patricia Aldea's work include Alzheimer's disease research and treatments (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Advanced Neuroimaging Techniques and Applications (3 papers). Patricia Aldea is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Advanced Neuroimaging Techniques and Applications (3 papers). Patricia Aldea collaborates with scholars based in United States and India. Patricia Aldea's co-authors include John C. Morris, Anne M. Fagan, David M. Holtzman, Jon Christensen, Beau M. Ances, Tammie L.S. Benzinger, Yi Su, Karl A. Friedrichsen, Nigel J. Cairns and Matthew R. Brier and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Patricia Aldea

8 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease

2016 535 citations Matthew R. Brier, Brian A. Gordon et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Patricia Aldea

Since Specialization

Citations

This map shows the geographic impact of Patricia Aldea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Aldea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Aldea more than expected).

Fields of papers citing papers by Patricia Aldea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Aldea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Aldea. The network helps show where Patricia Aldea may publish in the future.

Co-authorship network of co-authors of Patricia Aldea

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Aldea. A scholar is included among the top collaborators of Patricia Aldea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Aldea. Patricia Aldea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging 2016 ·Brain ·Brian A. Gordon, Karl A. Friedrichsen, Matthew R. Brier, Tyler Blazey, Yi Su, Jon Christensen, Patricia Aldea, Jonathan McConathy, David M. Holtzman, Nigel J. Cairns, John C. Morris, Anne M. Fagan, Beau M. Ances, Tammie L.S. Benzinger	134
2	O5‐01‐06: TAU Pet Imaging with AV‐1451 in Autosomal Dominant Alzheimer's Disease: Update from the Dominantly Inherited Alzheimer Network (DIAN) 2016 ·Alzheimer s & Dementia ·Tammie L.S. Benzinger, Brian A. Gordon, Karl A. Friedrichsen, Yi Su, Jon Christensen, Russ C. Hornbeck, Shruti Mishra, Patricia Aldea, Lisa Cash, Beau M. Ances, Jonathan McConathy, Robert A. Koeppe, Eric McDade, Nigel J. Cairns, John C. Morris, Randall J. Bateman, Virginia Buckles, (unknown)	4
3	Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy 2016 ·JAMA Neurology ·Liang Wang, Tammie L.S. Benzinger, Yi Su, Jon Christensen, Karl A. Friedrichsen, Patricia Aldea, Jonathan McConathy, Nigel J. Cairns, Anne M. Fagan, John C. Morris, Beau M. Ances	223
4	Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease breakdown → 2016 ·Science Translational Medicine ·Matthew R. Brier, Brian A. Gordon, Karl A. Friedrichsen, John E. McCarthy, Ari Stern, Jon Christensen, Christopher G. Owen, Patricia Aldea, Yi Su, Jason Hassenstab, Nigel J. Cairns, David M. Holtzman, Anne M. Fagan, John C. Morris, Tammie L.S. Benzinger, Beau M. Ances	535
5	IC‐01‐03: Classifying TAU Pet Positivity With [18F]‐AV‐1451 in Preclinical Alzheimer's Disease 2016 ·Alzheimer s & Dementia ·Shruti Mishra, Brian A. Gordon, Karl A. Friedrichsen, Yi Su, Jon Christensen, Patricia Aldea, Nigel J. Cairns, John C. Morris, Beau M. Ances, Tammie L.S. Benzinger	2
6	Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function 2015 ·PLoS ONE ·Yi Su, Tyler Blazey, Abraham Z. Snyder, Marcus E. Raichle, Russ C. Hornbeck, Patricia Aldea, John C. Morris, Tammie L.S. Benzinger	21
7	Cognitively unimpaired HIV-positive subjects do not have increased¹¹C-PiB 2010 ·Neurology ·Beau M. Ances, Jon Christensen, (unknown), John‐Paul Taylor, Chengjie Xiong, Patricia Aldea, Anne M. Fagan, David M. Holtzman, John C. Morris, Mark A. Mintun, David B. Clifford	44
8	Cerebrospinal fluid tau and ptau ₁₈₁ increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease 2009 ·EMBO Molecular Medicine ·Anne M. Fagan, Mark A. Mintun, Aarti R. Shah, Patricia Aldea, Catherine M. Roe, Robert H. Mach, Daniel S. Marcus, John C. Morris, David M. Holtzman	266

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact